Discover REMODEL Phase 3 findings evaluating remibrutinib in relapsing multiple sclerosis. Read more for clinical efficacy and safety data.

Nearly 80% of ICU ventilator alarms resolved within 10 seconds, highlighting opportunities to reduce alarm fatigue. Read more ...

Denosumab treatment beyond 12 months was linked to higher jaw necrosis risk without further reduction in skeletal events in ...

Epigenetic ageing in preterm children was associated with higher cognitive and motor scores, with severe brain injury ...

Lilly’s retatrutide outperformed on blood sugar control and weight loss in a phase 3 diabetes trial. US submission is planned ...

Hyperkalaemia in heart failure affected 28% of Malaysian patients, with chronic kidney disease significantly associated with ...

Telerehabilitation in multiple sclerosis showed no significant advantage over home-based exercise for physical function, ...

SGLT2 inhibitors were associated with higher haemoglobin and haematocrit levels in a meta-analysis of 85 randomised clinical ...

ECDC assessments show Europe is still not full prepared for another world health emergency despite improvement since COVID-19 ...

A cohort study assessed MASLD after surgery for hepatitis B-related liver cancer, highlighting BMI-related differences in ...

Remission was common 10 years after treat-to-target therapy in early rheumatoid arthritis. Discover why achieving remission ...

DWI-RECIST combined MRI measures with conventional criteria to improve early response classification in lung cancer bone ...